Mentor: Dr. Charleen Chu
Current Year in the Program: G1
Representative Publications
- Megli, C. J., Zack, R. K., McGaughey, J. J., Hoehl, R. M., Snisky, T., Hartman, A. L., & McMillen, C. M. (2025). Oropouche virus infects human trophoblasts and placenta explants. Nature Communications, 16(1), 6040.
- Kannarkat, G. T., Zack, R., Skrinak, R. T., Morley, J. F., Davila‐Rivera, R., Arezoumandan, S., ... & Chen‐Plotkin, A. S. (2025). Blood α‐Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies. Annals of neurology.
- Shen, J., Amari, N., Zack, R., Skrinak, R. T., Unger, T. L., Posavi, M., ... & Chen‐Plotkin, A. S. (2022). Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson's disease. Annals of neurology, 92(2), 255-269.
- Diaz-Ortiz, M. E., Seo, Y., Posavi, M., Carceles Cordon, M., Clark, E., Jain, N., ... & Chen-Plotkin, A. S. (2022). GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein. Science, 377(6608), eabk0637.
- Blömeke, L., Pils, M., Kraemer-Schulien, V., Dybala, A., Schaffrath, A., Kulawik, A., ... & Willbold, D. (2022). Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting. npj Parkinson's Disease, 8(1), 68.
- Tropea, T. F., Hartstone, W., Amari, N., Baum, D., Rick, J., Suh, E., ... & Chen-Plotkin, A. S. (2024). Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level. npj Parkinson's Disease, 10(1), 97.
Oral Presentations
- Zack, Rebecca. (2023, May 9). Plasma a-Synuclein Strains in Lewy Body Disease. [Oral Presentation]. Gordon Research Conference: Proteins, Pathway, and Pathophysiology in Parkinson’s. Les Diablerets, Vaud (fr), Switzerland.
- Kannarkat, George T*, Zack, Rebecca. (2023, March 31). PLASMA-DERIVED CONFORMATIONS OF ALPHA-SYNUCLEIN IN LEWY BODY DISORDERS. [Oral Presentation]. AD/PD 2023: Advances in Science & Therapy. Gothenburg, Sweden.